menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

AVAX TECHNOLOGIES (AVXT)
0.0015 0 (0%)  01-18 10:04
Open: 0 Prev Close: 0.0015
High: 0 Low: 0
Volume: 0 Market Cap: 1M
Year High: 0.0096 Year Low: 0
Stock Technical Analysis
Overall       
Targets Six months: 0.0034    One year: 0.0047
Supports Support1: 0.0012   Support2: 0.0010
Resistances Resistance1: 0.0029    Resistance2: 0.0040 
Pivot Point 0.0020 
Moving Averages MA(5): 0.0017      MA(20): 0.0020 

MA(100): 0.0023  1     MA(250): 0.0027 
MACD MACD(12,26):       Signal(12,26,9):  
Stochastic Oscillator %K(14,3): 13.810      %D(3): 15.873 
RSI RSI(14): 44.642 
52-Week High: 0.0096  Low: 0.0010  Change(%): -46
Average Volume(K) 3-Month: 4875  10-Days: 508
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BEARISH in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed above bottom band by 25.2%; Bollinger Bands are 37.7% narrower than normal.The current width of the bands does not suggest anything about the future direction or movement of prices.

Stoxline

Stock Chart

Top 100 stocks

Stock News
AVAX Technologies Announces Results Of Its OVAX, Ovarian Cancer Vaccine, Phase ...
Tue, 26 Jan 2016 23:11:16 GMT

AVAX Technologies, Inc. Announces the Appointment of Chief Executive Officer
Mon, 19 Oct 2015 12:04:03 GMT

Philadelphia biotech firm resolves debt dispute with cancer hospital
Wed, 05 Aug 2015 17:48:45 GMT

Global Personalized Cancer Vaccines & Clinical Innovation Outlook 2017-2022 ...
Thu, 23 Feb 2017 14:36:49 GMT

Heat Biologics Appoints Dr. John Prendergast to Board of Directors
Mon, 25 Apr 2016 10:52:30 GMT

​Five things you don't know about Jeff Jonas, CEO of Sage Therapeutics
Fri, 12 Jun 2015 18:55:49 GMT

Global Cancer Immunology and Oncolytic Virology Technologies and Markets 2015 ...
Tue, 25 Jul 2017 12:56:15 GMT

Global Breast Cancer Vaccine Market & Clinical Pipeline Outlook 2022: First ...
Mon, 06 Mar 2017 13:52:30 GMT

Cancer Immunotherapy, Part 1: Current Strategies and Agents
Sun, 28 May 2017 19:41:43 GMT

Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations
Fri, 23 Jun 2017 15:02:33 GMT